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ABSTRACT: Understanding the issue of specificity imposed in the interactions of SH3 domains has largely
been addressed in studies investigating the interaction of proline-rich amino acid sequences derived
from potential ligands for these domains. Although the interaction with this motif forms an essential
platform in the binding of SH3 domains, in many cases little specificity is observed and the difference in
affinity for so-called specific and nonspecific proline-rich sequences is not great. Furthermore, the binding
interface between an SH3 domain and a protein ligand appears to encompass more interactions than are
represented by that involving the proline-rich motif. Here we investigate the issue of specificity from the
opposite point of view; namely, how does a ligand recognize different SH3 domains? We present the
crystal structure of the unbound SH3 domain from hemopoietic cell kinase (Hck) which is a member of
the Src family of tyrosine kinases. This structure reveals that, unlike the structures of other Src kinase
SH3 domains, the RT loop region is highly mobile and lacks a network of hydrogen bonds that is elsewhere
apparent. The RT loop has been shown to form a major part of the binding interface between SH3
domains and HIV-1 Nef. Thermodynamic data, derived from isothermal titration calorimetry, for the
binding of Hck SH3 to HIV-1 Nef show that the binding of Hck (KD ) 1.5 íM) is approximately an
order of magnitude tighter than those of other Src family kinases that were investigated (Fyn, Lck, and
Src). This increase in affinity is attributed to, among other effects, the inherent flexibility in the RT loop
which does not require breaking the network of hydrogen bonds to adopt the conformation required for
binding.
The defining interaction for Src homology 3 (SH3)1
domains was initially deemed to be with that of a polypro-
line-based sequence on the surface of the ligand (1, 2).
Structural studies subsequently revealed that the ability of
these sequences to adopt a left-handed polyproline type II
(PPII) helical conformation was necessary for specific
binding (3-9). A plethora of studies attempted to identify
how a given SH3 domain can discriminate between various
proline-rich sequences in peptides derived from potential
physiological ligands (5, 9, 11-15). Some SH3 domains
do have a weakly delineated preference for some proline-
rich sequences. However, since the PPII helix is a common
secondary structural element found on the surface of many
globular proteins, and the site of interaction of this helix on
the SH3 domain is essentially featureless, being formed
between highly conserved hydrophobic residues, additional
specificity is likely to be derived elsewhere in the biomo-
lecular interface. Binding studies between SH3 domains and
proteins suggest that there are significant interactions over
and above those represented by the burial of the proline-
rich motif (16, 17). Recent X-ray crystallographic data on
the complex between the SH3 domain from the Src family
protein Fyn and the Nef protein of human immunodeficiency
virus 1 (HIV-1) (18, 19) confirm that there is a large
interfacial contact surface (which contains the canonical
ProXxxXxxPro motif; where Xxx is any amino acid). Thus,
although providing a necessary platform, the interaction of
the proline-rich sequence with an SH3 domain is not entirely
sufficient for dictating specificity.
Here we address the issue of specificity from a different
perspective; namely, what are the features of SH3 domains
which allow a protein ligand to discriminate between them?
For this investigation, we adopt the interaction of HIV-1 Nef
with SH3 domains from the Src family. This requires the
correlation between structural detail and thermodynamic data
for complex formation. We present the crystal structure of
the unbound SH3 domain from hemopoietic cell kinase
(Hck), a member of the Src family. The structures of the
† This study was supported by funding from the ANRS and FRM
Sidaction. S.A. is a Predoctoral Fellow of Ministe´re de l’Enseignement
Supe´rieur et de la Recherche. J.E.L. is a Wellcome Trust Senior
Research Fellow.
‡ The structure of the SH3 domain from Hck has been assigned the
Brookhaven Database PDB filename 0000.
* Address correspondence to this author.
§ Universite´ Montpellier 1.
| University College London.
1 Abbreviations: SH3, Src homology 3; Hck, hemopoietic cell kinase;
HIV, human immunodeficiency virus; Nef, negative factor; ITC,
isothermal titration calorimetry; GST, glutathione-S-transferase; PPII,
polyproline type II helix; RT loop, loop in SH3 structure named after
arginine, R, and threonine, T, residues commonly found in it.
14683Biochemistry 1998, 37, 14683-14691
10.1021/bi980989q CCC: $15.00 © 1998 American Chemical Society
Published on Web 10/01/1998
isolated ligand-free SH3 domain from Fyn (20, 21), Src (22),
and Lck (23) have been previously reported. Furthermore,
the structures of the full-length ‘auto-regulated’ or ‘closed’
form of the tyrosine kinases Src and Hck, in which the SH3
domain forms an intimate interaction with the intramolecular
kinase domain, have also been determined (24, 25, respec-
tively). These structures reveal that, despite the high level
of homology between the sequences of these Src family SH3
domains (Figure 1), significant amino acid substitutions occur
on the surface which is likely to constitute the Nef interface
outside the proline-rich binding site region. Thermodynamic
data on the interactions of these SH3 domains in light of
this structural information enable definition of the salient
features in their recognition by Nef.
The human immunodeficiency virus HIV-1 Nef protein
binds with varying affinity to a subset of SH3 domains from
proteins in the Src family of tyrosine kinases [Fyn, Hck, Lck,
and Lyn (26, 16, 27, 28, respectively)]. Although this protein
has no known catalytic activity, on viral infection it is one
of the first to be produced at high levels. Nef is encoded
by human and simian immunodeficiency viruses (HIV and
SIV) where it is necessary for efficient replication of the
virus and the development of the pathology associated with
AIDS. Two major effects of Nef on cell function have
consistently been described (for reviews, see 29, 30): (1)
the induction of alterations in cellular signal transduction
pathways; and (2) the down-regulation surface expression
of CD4 (primary viral receptor in T-cells), and MHC class
1 molecules (31, 32). The correlation between the increase
in infectivity and the interaction of Nef with SH3 domains
from Src family kinases has been established. Furthermore,
direct evidence for the effects of binding to SH3 domains
of Src family kinases has been demonstrated. For example,
the formation of the Nef-Hck complex, which is necessary
and sufficient for the transformation of Rat-2 fibroblasts, was
completely blocked by mutagenesis of the Nef proline-rich
motif (33). Fyn and Lck are functionally associated with
the T-cell antigen receptor (TcR)/CD3 receptor complex and
are activated during the course of TcR and CD4 engagement.
Nef blocks the early events in TcR/CD3 signaling (34) and
is very likely to do so upon association with the Src kinases
Lck and Fyn. As Lck is associated with CD4, the binding
of Nef to Lck may well play a key role in Nef-mediated
down-regulation of CD4 (35-37). There is no direct
evidence for the in vivo interaction of HIV-1 Nef with Src;
however, association has been reported in the case of a Nef
isolate from simian immunodeficiency virus (SIV) (38).
Based on the homology of SH3 domains from the Src family
tyrosine kinases, we decided to include this domain in this
investigation as a further probe of specificity. The involve-
ment of the Nef-SH3 domain interactions in the infectivity
of HIV-1 has made it the focus of a number of drug design
efforts, and therefore, understanding the determinants of
specificity in its interactions is fundamental to pharmaceutical
intervention.
The structural detail and the thermodynamic data reveal
the importance of interactions outside those represented by
the proline-rich motif interface. Particular importance is
attributed to the interaction of the RT loop region from the
SH3 domains, and the differences in the thermodynamic
parameters of the studied Src family SH3 domains can be
attributed (at least in part) to the effect of the inherent
flexibility of this loop in binding.
EXPERIMENTAL PROCEDURES
Preparation of Recombinant Proteins. HIV-1 LAI Neffull
length (residues 1-206), Nef¢1,57 (residues 58-206), and the
SH3 domains of Hck (residues 82-142 of full-length Hck),
Src (residues 82-142), and Fyn (residues 72-142) were
expressed in Escherichia coli as fusion proteins with glu-
tathione-S-transferase (GST) utilizing the pGEX-2T gene
fusion vector (Pharmacia). All constructs were transformed
into E. coli BL21 cells (Pharmacia), except the Src SH3-
GST plasmid, that was transformed into E. coli DH5R cells.
The Lck SH3 domain (residues 63-120) was cloned as a
GST fusion protein in the pGEX 3X vector containing a
factor Xa cleavage site and expressed in E. coli DH5R cells.
Cells grown overnight at 37 °C in Luria-Bertani medium
containing 1 mg/mL ampicillin were diluted 1:50 into fresh
medium and grown at 37 °C for 3-4 h until an optical
density of 0.6 at ì ) 600 nm. Isopropyl â-D-thiogalacto-
pyranoside was then added to 0.2 mM, and the cells were
grown for an additional 2-3 h. Cells were harvested by
centrifugation (3000g for 30 min) and stored at -80 °C. For
purification, the frozen cells were resuspended in 10 volumes
of ice-cold resuspension buffer [PBS buffer (GibcoBRL),
2.5 mM EGTA (BDH Biochemical), 5 mM benzamidine
(Sigma), and in the case of Nef, 5 mM dithiothreitol (BDH
Biochemical)]. Prior to mild sonication on ice (4  20 s),
1% Triton and 5 mM phenylmethylsulfonyl fluoride (PMSF,
Sigma) were added. The lysed cells were centrifuged
(50000g for 1.5 h), and the pellet was discarded. The
supernatant was loaded onto a glutathione-Sepharose 4B
FIGURE 1: Sequence alignment of Src family SH3 domains from Hck, Fyn, Lck, and Src showing regions associated with secondary
structural elements common to Src family SH3 domains. The figure also highlights amino acids (a-k) involved in binding to HIV-1 Nef
(19). Light gray: nonspecific interactions with the Nef ProXxxXxxPro region of Nef. Dark gray: specific ‘tertiary’ interactions. Asterisk:
Amino acid implicated as possibly binding in modeling studies herein reported.
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column (Pharmacia) and equilibrated in resuspension buffer.
The beads were then extensively washed with 100 bed
volumes of 1 M NaCl in resuspension buffer to eliminate
nonspecifically fixed products, and equilibrated in the
cleavage buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
2 mM CaCl2, and 5 mM DTT in the case of Nef). The
proteins were cleaved from the fused GST protein on the
column matrix by overnight treatment at room temperature
with 7-10 unitsâmL-1 bovine thrombin (CalBiochem) (Nef,
Hck, Src, and Fyn) or 10 íg of factor Xa (Pharmacia) (Lck)
per milligram of fusion protein. The thrombin and factor
Xa cleavage was stopped with 5 mM benzamidine and 5
mM DTT, respectively. The cleaved proteins were eluted
and their purity confirmed by SDS-PAGE. Proteins that
were readily >95% pure (Lck SH3, Src SH3, and Neffull length)
were concentrated using 3 kDa cutoff ultrafiltration (Amicon)
and dialyzed against the titration buffer [20 mM phosphate
buffer (BDH Biochemical), pH 7.5, 150 mM NaCl, 2 mM
EGTA, and 5 mM DTT]. Proteins showing contaminants
(Nef¢1,57, Hck, and Fyn SH3) were further purified using
size exclusion chromatography (Pharmacia S-100 HR).
Fractions containing >95% pure protein were pooled,
concentrated, and dialyzed against the titration buffer for
thermodynamic analysis. For crystallization experiments, the
Hck SH3 domain was dialyzed against 20 mM Tris-HCl,
pH 8.0, 100 mM NaCl, and 1 mM EGTA and concentrated
by ultrafiltration up to 6 mg/mL.
The integrity of the purified proteins was checked by mass
spectroscopy and N-terminal sequencing. Protein concentra-
tions were estimated by UV absorption of aromatic residues
at 280 nm using the following extinction coefficients: Hck,
Src, Fyn SH3 domains, 280 nm ) 16 500 M-1 cm-1; Lck SH3
domain, 280 nm ) 12 660 M-1 cm-1; full length Nef, 280 nm
) 49 150 M-1 cm-1; and Nef¢1-57, 280 nm ) 31 960 M-1
cm-1.
Crystallization. Crystals of the Hck SH3 domain were
grown by vapor diffusion with the hanging drop technique
at 21 °C. For crystal growth, 1 cmc of octyl â-glucoside
was added to the protein solution containing the purified Hck
SH3 domain at a concentration of 4.3 mg/mL in its storage
buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 1 mM
EGTA). For one crystallization experiment, 2 íL of this
protein solution was mixed with an equal volume of the well
solution [100 mM bicine, pH 9.3, 3.7 M sodium formate,
2% poly(ethylene glycol) (PEG 3000)]. Crystals grew
reproducibly over a period of 1 week with final dimensions
of (350  350  100) ím in the best cases. Hck SH3
crystals belong to space group P21212 with cell dimensions
of a ) 51.50 Å, b ) 106.15 Å, and c ) 78.80 Å. Six
independent Hck SH3 molecules were present in the asym-
metric unit, resulting in a Matthews coefficient of 2.6 Å3/
Da.
Data Collection. Diffraction data up to 2.6 Å resolution
were recorded at 1.074 Å at the ESRF synchrotron light
source (beamline D2AM) in Grenoble, France, on two
different crystals grown under identical conditions. Data
from both crystals were processed with an adapted version
of the XDS program (39) and merged to finally obtain a
93% complete data set (62% for the last resolution shell
between 2.6 and 2.72 Å spacings) containing 13 043 unique
reflections between 34 and 2.6 Å resolution.
Structure Determination and Refinement. The structure
was determined by molecular replacement with the AMoRe
program (40) using the Hck SH3 domain from the published
Hck kinase (PDB entry 2HCK, 25) as molecular template.
Five of the expected six molecules could be placed by
AMoRe. The last molecule was retrieved by iterative phase
improvment using a partial model corresponding to the five
SH3 molecules and a molecular envelope covering all six
molecules. The missing SH3 molecule was clearly identifi-
able in the resulting 2Fo - Fc map and was unambiguously
fitted into this density.
Model refinement was carried out using X-PLOR (41).
Bulk-solvent corrections and anisotropic temperature factor
scaling were applied during refinement. Program ‘O’ (42)
was used for visualization and model building, PROCHECK
(43) and WHAT IF (44) for displaying the quality of the
model. All recorded data from 34 to 2.6 Å were used in
refinement. All loop regions were rebuilt into the simulated
annealing omit maps calculated by X-PLOR. The final
model comprises 6 Hck SH3 molecules (A-F, including
residues 84-140 following the conventions used for the Hck
kinase) and 75 water molecules. The final model shows
good stereochemistry: the rms deviations for ideal bond
distances and bond angles are 0.010 Å and 1.27°, respec-
tively. Main chain  and ª torsion angles for 90% of the
non-glycine residues fall within the most-favored region of
the Ramachandran plot. The final crystallographic R factor
for all reflections between 34 and 2.6 Å resolution is 23.3%,
and the Rfree value is 29.7%. The overall temperature factors
for the six SH3 molecules are 18.4, 21.5, 22.5, 27.7, 28.6,
and 29.7 Å2, respectively.
Isothermal Titration Calorimetric (ITC) Experiments.
Titration experiments were carried out with an MCS
calorimeter (MicroCal Inc., Northampton, MA) (45, 46), and
performed as described in (47). Before titrations, both
reactants were dialyzed exhaustively, in the same container,
against the titration buffer: 20 mM phosphate buffer, pH
7.5, 150 mM NaCl, 2 mM EGTA, and 5 mM DTT. Just
prior to a titration experiment, the solutions for the syringe
and for the cell were thoroughly degassed by stirring under
vacuum. Protein concentrations were determined spectro-
photometrically by measuring their absorbance at a wave-
length of 280 nm. For all reactions, the concentration of
the reactant in the syringe was about 10 times greater than
in the ITC reaction cell. The protein solutions were injected
from a 250 íL capacity syringe into the 1.3 mL calorimeter
cell containing the reactant solution. A titration consisted
typically of 16-26 injections of 12 or 15 íL of SH3 domain
(200-600 íM), respectively, into the isothermal cell con-
taining Nef protein (20-60 ím) at a temperature of 25 °C.
Five minutes were allowed between injections for equilibra-
tion.
Experimental data were fit using the nonlinear least-
squares algorithm (45) utilizing ORIGIN software (MicroCal
Inc.). The heats of dilution for interaction were determined
in separate titration experiments by injecting protein solution
from the syringe into the appropriate buffer solution in the
ITC reaction cell. The heats determined from these experi-
ments were used to correct the titration data prior to data
analysis. There was no evidence of associated states of any
of the interacting components as assessed by heats of dilution
experiments.
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Homology Modeling. The crystal structures of HIV-1
Nefcore complexed with the Ile96Arg and wild-type Fyn SH3
domain (PDB entries 1EFN and 1AVZ) were used as
molecular template for modeling of the complexes between
Nefcore and Hck, Lck, and Src SH3 domains. The optimal
set of rotamers for the mutated residues was established by
cluster analysis of an energy matrix as implemented in the
SMD program (48) The modeled complexes containing the
new rotamers were then minimized by AMBER (49) in a
vacuum using a distance-dependent dielectric constant of 
) r. Minimization was carried out under various constraints
that were gradually released. The same protocol applied to
the original crystal structures yielded modeled structures that
were very close to the initial coordinates (rms deviation for
all non-hydrogen atoms of 0.7 and 0.8 Å for 1EFN and
2AVZ, respectively).
RESULTS AND DISCUSSION
General Features of the Structure of the SH3 Domain from
Hck. The Hck SH3 domain forms crystals with six inde-
pendent molecules in the asymmetric unit related by improper
symmetry (see Experimental Procedures). The overall fold
of the Hck SH3 domains is the same as reported for the
isolated unbound Fyn SH3 domain (20) and for the Hck
domain in the context of the whole kinase in the ‘closed’
conformation (25): five antiparallel â-strands fold into a
â-barrel of two orthogonal â-sheets connected by three loops
(the RT loop, the nSrc loop, and the distal loop) as shown
in Figure 2. A short 310 helix is located near the C-terminal
(residues 134-137). The CR trace of the six independent
SH3 molecules of the asymmetric unit can be superimposed
within an rmsd of 0.47 Å, and the CR traces of the free Hck
SH3 structures deviate from the mean Hck SH3 domain
bound to the SH2 domain-kinase domain linker sequence
structure (PDB entry 2HCK; 25) by an rmsd of 0.7 Å.
Perhaps the most noticeable feature of the Hck SH3 structures
of the asymmetric unit are the differences in the backbone
conformation in the loop regions (Figure 3A). Comparison
of the six Hck SH3 domain molecules showed that the largest
differences in the CR coordinates from the mean structure
were found for histidine 98 of the RT loop (0.42 Å), for
alanine 126 of the distal loop (0.86 Å), and for serine 115
from the n-Src loop (0.40 Å). Within the six independent
structures, many side chains of the loop regions were found
in different conformations, and often residual density was
observed next to side chain positions, suggesting the pos-
sibility of alternative conformations.
Incongruence of RT Loop Conformations between Src
Family SH3 Domains. The RT loop region (residues 90-
108) plays a key role in the binding interface in the structure
of the Fyn SH3-Nef complexes (18, 19). There is consider-
able variation in the residues present in the sequences of the
RT loops of Src family SH3 domains (Figure 1), suggesting
that this region could be important in dictating specificity
(16). Comparing structural data on the RT loops of the
unbound SH3 domains of Hck and Fyn, in the latter this 19
residue region incorporates an intricate network of hydrogen
bonds in which Asp100 plays a central role. This residue
potentially forms five hydrogen bonds via its carboxylate
group with the side chains of Tyr93 and Thr97 as well as
FIGURE 2: Ribbon diagram of Hck SH3 domain showing essential
structural features.
FIGURE 3: Incongruency of the RT loop region of the SH3 domain
from Hck. (A) Superposition of the six crystal structure forms of
Hck showing loop flexibility (slightly different orientation to that
shown in Figure 2). The line corresponds to a trace of the main
chain RC atoms from the crystal structure. (B) Graphical repre-
sentation of the difference in temperature (B) factors between the
SH3 domains from (solid line) Hck and (dotted line) Fyn (20) and
the root-mean-square deviation of a single Hck SH3 structure (RC
trace; dashed line) from the mean structure from the six crystal
forms in the asymmetric unit. Both figures emphasize the relative
disorder in the RT loop region.
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with the main chains of Thr97 and Arg96. Additional
hydrogen bonds are apparent between the side chain of Arg96
and the proximal main chain of Tyr132 of the underlying
âD-strand. Although Asp100 is conserved in the Hck SH3
domain (as it is in most SH3 domains), two substitutions
(Arg96Ile, Thr97His) preclude the hydrogen bonding network
seen in Fyn from forming (Figure 4). This is reflected in
the increased flexibility of the RT loop of Hck observed in
our structural data described above. Indeed, in the crystal
structure of Hck, the two histidines (His97 and -98) in the
RT loop are so highly mobile in the unbound state that
electron density is often badly defined for the main chain
(molecules C, E, and F) and partly or totally absent for most
of the side chains (molecules B, C, E, and F). As mentioned
above, our crystal structure reveals considerable differences
in conformation of the RT loops of the six molecules in the
asymmetric unit. The average main chain atom temperature
factors for these RT loops (Figure 3B) are 38 Å2 (compared
to the main chain average of 17 Å2) whereas in the Fyn SH3
domain this value is significantly lower (25 Å2, 20). Both
Arg96 and Tyr97 are conserved in the Src SH3 domain,
resulting in restriction of mobility of the RT loop observed
in Fyn. In Lck, substitution of Arg96Ser and Tyr97His could
result in the highly flexible RT loop as observed in Hck;
however, the presence of Pro95 is likely to significantly
reduce the mobility in this region.
In two of the six Hck molecules (molecules A and D),
the Asp100 deviates from its position in the center of the
RT loop compared to the other four molecules and to the
structure of the whole kinase (25). In a structural superposi-
tion of Asp100 in Hck molecules A and C, the orientation
is the same as that in the Fyn SH3 domain in complex with
Nef. In this complex, Fyn Asp100 bends away from its
central position in the RT loop and forms a salt bridge with
Arg77 in Nef. The flipping of this Asp results in the
aforementioned hydrogen bonding network being broken,
resulting in an increase in flexibilty of the loop to interact
with the rest of the Nef surface (19). The RT loop is able
to adopt a structure which affords a number of hydrogen
bonding interactions with Nef. The A and D crystal forms
emphasize the strong propensity of Asp100 to form a salt
bridging interaction; however, interestingly, this residue is
unable to form such a bond in the intramolecular interactions
of the SH3 domains in the ‘closed’ full-length Src and Hck
structures (24, 25). Thus, Asp100 salt bridge formation
appears to be a signature of a specific interaction.
Thermodynamics of Binding of Nef¢1-57 to Src Family SH3
Domains. To understand the determinants of specificity, the
structural detail from the X-ray crystal structure described
herein, and from those previously reported, is correlated to
thermodynamic data derived from ITC. Since all the
currently reported structural information on Nef-SH3 com-
plexes is based on deleted forms of the protein [¢1-55, (18);
¢1-57, (19)], we initially report binding data on the deleted
form first described by Arold et al. (19). The unliganded
Nef¢1-57 construct shows disorder in the N-terminal region
from residues 58-73 which includes part of the polyproline
region [residues 71-77; (19, 50)]. In the bound form,
residues 71-77 adopt the PPII helical conformation with
the second half of the polyproline region (74-77) anchored
through hydrogen bonding to the Nef core domain (residues
118-121). The dissociation constants for the interactions
between Nef¢1-57 and the SH3 domains from Hck, Fyn, Lck,
and Src are all within an order of magnitude of one another
(Table 1). Clearly, there is only limited specificity between
these interactions; however, within this subset of Src family
ligands, Hck binds significantly more tightly than the others.
The physiological relevance of this higher affinity is not
clear. Fyn, Lck, and Src tyrosine kinases are widely
expressed, whereas Hck expression is restricted to hemato-
poietic cells from the monocyte/macrophage lineage. Thus,
in the absence of Hck in CD4+ T-cells and assuming that
the SH3 domain interaction is the only determinant, Nef
targets other Src family kinases but with little apparent
preference for binding.
The thermodynamic data reveal that for all the SH3-Nef
interactions at 25 °C both the ¢H and T¢S provide a
favorable contribution to ¢G (Table 1). However, in the
case of Hck, the ¢H is the most favorable (-32.6 kJâmol-1),
and the T¢S is the least favorable (0.7 kJâmol-1). To analyze
the detail of binding specificity, we divide our discussion of
these into several independent components. (1) The burial
of surface area. The overall favorable entropic contribution
to binding in all cases is likely to arise from the dominant
effect of the burial of hydrophobic surface area, since on
forming the complex water molecules which were ordered
FIGURE 4: Difference between the RT loop regions of Hck and
Fyn showing hydrogen bonding conformations. Note the reduction
in the extent of the restrictive network of hydrogen bonds in the
Hck which is apparent in the Fyn structure centered around Thr97,
Arg96, and Asp100.
Table 1: Isothermal Titration Calorimetric Data for the Binding of
HIV-1 Nef to SH3 Domains from Src Family Tyrosine Kinases at
25 °C
KD
(íM)
¢G
(kJâmol-1)
¢H
(kJâmol-1)
T¢S
(kJâmol-1)
Nef¢1-57 Hck 1.5 -33.3 -32.6 0.7
Nef¢1-57 Fyn 15.8 -27.4 -2.2 25.2
Nef¢1-57 Lck 10.6 -28.4 -7.0 21.4
Nef¢1-57 Src 14.3 -27.6 -16.2 11.4
Nef¢1-57b Hck 1.5 -33.3 -21.6 11.7
Nef¢1-57b Src 8.3 -28.9 -13.1 15.8
Neffull length Hck 0.6 -35.5 -62.8 -27.3
Neffull length Src 11.4 -28.2 -41.8 -13.6
a Reported data are based on the means of two individual ITC
experiments. All the stoichiometries of the interactions reported are
1.0 ( 0.2 based on nonlinear least-squares fitting of the ITC data (45).
For conditions for ITC experiments, see Experimental Procedures. b In
buffer containing 0.5 M NaCl.
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on this surface are released into the bulk solvent. Table 2
confirms that a large amount of apolar surface is, indeed,
buried in all the interactions. This seems to be a common
feature associated with SH3 domain binding as was hypoth-
esized in the interaction of Fyn with the p85 subunit of PI3-
kinase (17). It is worth noting that the interaction of the
Hck SH3 domain with Nef involves burial of the largest
surface area which would be accompanied by the largest
number of released water molecules and hence, in the
absence of any other effects, providing the largest favorable
entropic contribution of all the interactions. This event is
not manifested in the thermodynamic data (Table 1). There
is no apparent trend between the burial of surface area and
the KD for the other Src family SH3 domains. (2) The SH3-
Nef PPII helix interaction. The residues in the Src family
SH3 domain interactions with the Nef PPII helix are highly
conserved (see Figure 1); thus, this region offers little in the
way of specificity. Table 2 and Figure 5 indicate the
importance of this part of the interface in providing a large
hydrophobic surface for interaction. However, the SH3
2 The structures described by the PDB filenames in Table 2 are as
follows: X 1EFN and X 1AVZ refer to the crystal structures of HIV-1
Nefcore to FynR96I SH3 and Fynwt, respectively. M 1EFN and M 1AVZ
designate the minimized PBD entries. c-Src 1EFN and c-Src 1AVZ
refer to the c-Src SH3-Nef complex modeled on the basis of the PDB
entries 1EFN and 1AVZ, respectively.
Table 2: Surface Areaa Burial on Formation of Complexes between HIV-1 Nef and SH3 Domains from Src Family Kinases
total apolar (% of total) SH3 Nef PPII-SH3 (% of total) surfaceb surfacec surfaced
X 1EFN 1205 722 (60) 604 596 714 (60) 293 262 198
M 1EFN 1288 736 (57) 638 650 761 (59) 297 273 188
X 1AVZ 1278 684 (53) 637 641 700 (55) 253 314 131
M 1AVZ 1282 735 (57) 612 680 674 (52) 300 303 148
c-Src 1EFN 1275 713 (56) 619 656 777 (61) 265 248 147
c-Src 1AVZ 1275 705 (55) 600 675 679 (53) 270 289 130
Hck 1EFN 1474 811 (55) 728 746 827 (56) 353 330 220
Lck 1EFN 1396 720 (52) 700 696 798 (57) 296 330 177
a All areas are given in Å2. Solvent accessibilities were calculated with a rolling sphere of radius of 1.4 Å. The modeling protocol leads to a
slight overestimation of the buried surface area of about 2-5%. To show bias introduced by the modeling procedure, the minimized PDB coordinates
have been included. To show model bias, the complex between HIV-1 Nef and c-Src SH3 is calculated twice, once modeled on the PDB entry
1EFN and once based on 1AVZ. Models: X 1EFN and X 1AVZ refer to the crystal structures of HIV-1 Nefcore to FynR96I SH3 and Fynwt, respectively.
M 1EFN and M 1AVZ designate the minimized PBD entries. c-Src 1EFN and c-Src 1AVZ refer to the c-Src SH3-Nef complex modeled on the
basis of PDB entries 1EFN and 1AVZ, respectively. Surface areas: total ) total buried surface area (Nef + SH3); apolar (% of total) ) buried
hydrophobic atoms, which make X% of “total”; SH3 ) buried surface on the SH3 domain; Nef ) buried surface on Nef; PPII-SH3 (% of total)
) buried surface between the PxxP region and the adjacent SH3 residues, making X% of “total” (100 - X ) % of buried surface area for tertiary,
non-PxxP-mediated interactions). b Hydrophobic surface within buried surface area for tertiary, non-PxxP-mediated interactions. c Buried surface
belonging to SH3 residues contacting tertiary, non-PxxP areas on Nef. d Hydrophobic surface within surface.c
FIGURE 5: Binding surface of Src family SH3 domains showing difference between charged/polar (positive ) blue and negative ) red) and
hydrophobic residues (green). The lower case lettering corresponds to residues involved in binding (see Figure 1). The figure on the left
corresponds to the complex between Fyn SH3 (top, space-filling model) and HIV-1 Nefcore (below, single-strand model) derived from
Arold et al. (19). This shows the essential sites of interaction. The PPII helix of Nef (purple) is shown interacting with the hydrophobic
surface on the SH3 domain. Also shown are the structures of the unbound SH3 domains from Fyn, Hck, Src, and Lck. The unbound SH3
structures emphasize the similarity of the binding sites presented to interact with HIV-1 Nef.
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interactions involve a significant amount (almost 50%) of
surface area burial which is derived from outside interactions
made with the PPII helix (Table 2). (3) The RT loop
interaction. The different residues seen in the RT loop
appear to be able to offer some level of specificity. The
prime example of this is that Ile96 in the Hck SH3 domain
structure is undoubtedly able to probe into a deep pocket on
the surface of Nef [as can be ascertained from the Arg96Ile
mutation in Fyn (16, 18)]; however, it is not clear that this
should result in a much stronger interaction than that
associated with the Arg96 residue which is present in the
Fyn and Src domains. Furthermore, the interaction of Hck
SH3 is likely to be greatly affected by the observation that
in the complex interface with Ile96 a water molecule is
incorporated (19) whereas in Fyn, where Arg96 occupies the
same deep pocket, the water is not present (18). The
restriction of this water molecule into the binding interface
involves an entropic cost. It is not possible to determine
whether the enthalpic gain from hydrogen bonding of this
water at the base of the pocket gives rise to an overall
favorable ¢G (51). In the case of the RT loop from Lck,
the presence of the hydroxyl group on Ser96 is believed to
interact unfavorably with the hydrophobic region of the deep
pocket found on the Nef binding site, hence reducing the
affinity despite the expected flexibility in the RT loop found
in the absence of Arg96 and Thr97 (as discussed below).
Figure 5 suggests that one major difference in the binding
sites offered to the Nef protein by the SH3 domains is in
position 98 where Hck has a His residue whereas Fyn, Src,
and Lck have acidic side chains; however, previously
reported mutation studies (16) suggest that this is not the
case.
The interactions of individual residues, therefore, are
unlikely to be solely responsible for the difference in affinity
between Hck and the other Src family SH3 domains binding
to Nef. The major differences between the ¢H and T¢S
terms for Hck compared to the others appear to reflect the
increased flexibility of the RT loop region in the former
(assuming that Nef does not undergo any significant struc-
tural changes between the various SH3 complexes). Part of
the interaction of the SH3 domains requires that the RT loop,
in forming its intimate interaction with Nef, assumes a tightly
bound rigid conformation in which noncovalent bonds are
formed (negative ¢H) and conformational entropy is lost
(reduced T¢S). As opposed to Hck, in the other SH3 domain
interactions (Fyn and Src) the RT loop in the unbound form
is restricted by hydrogen bonds which have to be broken
before the RT loop can form the required conformation in
the bimolecular interface. This requirement to release the
RT loop from its more restricted conformation in the
unbound form results in a less favorable ¢H (compared to
Hck) due to breaking of hydrogen bonds (see Table 1). On
the other hand, the inherent flexibility of the Hck RT ensures
that a larger entropic penalty is incurred on binding, whereas
in the other SH3 domains going from one restricted
conformation (in the unbound form) to another (in the
complex) requires less of a penalty and hence the more
favorable net T¢S values observed.
The affinity of Nef for Fyn, Lck, and Src is remarkably
similar; however, the thermodynamic parameters that con-
tribute to the free energy reveal that the interactions are
somewhat different. This is emphasized in the difference
in the ¢H and T¢S values for the Fyn and Src SH3 domains
despite their having a high level of consistency in residues
implicated in the binding site with Nef (Figure 1). Indeed,
all but one (Thr99) of the amino acid sequence variations
between Fyn and Src occur outside the presumed binding
site for Nef. This suggests that perhaps the overall stability
of the SH3 domain structure is important in dictating the
thermodynamics of binding as has been previously inferred
for Hck (52).
Effect of Salt Bridge Formation on Binding. The structures
of the complexes show that a salt bridge forms between
Asp100 of the Fyn SH3 domain and Arg77 of Nef. Both
Asp100 and Arg77 are highly conserved in SH3 domains
and Nef, respectively. Arg77 plays a key role in the
polyproline region and is anchored to the Nef structure
through a series of hydrogen bonds locking residues 74-77
into a PPII helix conformation even in the absence of ligand.
This salt bridge is located within the center of the interface,
and the crystal structure shows clearly defined electron
density for both contributing residues (19). Additional
charge-charge interactions flanking the binding site are
expected from modeling studies. For example, Nef Lys82
is well positioned to interact with Glu99 of Hck, Glu98 of
Fyn or Src, and Asp98 of Lck. Unlike Asp100-Arg77, the
interaction of Nef Lys82 and Fyn Glu98 is not observed in
the crystal structures of the Nef-Fyn SH3 complexes,
probably as a result of these structures being derived from
crystals grown in high concentrations of salt (1 M). Model-
ing studies also suggest that both Hck and Lck can invoke
the interaction of Glu118 from the SH3 domain with Nef
Leu76.
Performing ITC experiments at high salt lowers the
ionization strength of the interacting residues, reducing the
potential for salt bridge formation. Table 1 shows that in
both Hck and Src 0.5 M salt has a negligible effect on affinity
compared to the data in 0.15 M salt. However, in both the
loss of the salt bridging interaction appears to give rise to
an increase in enthalpy and entropy compared to the
interaction in 0.15 M salt (for Hck SH3, ¢¢H0.5-0.15 ) 13.8
kJâmol-1; T¢¢S0.5-0.15 ) 13.7 kJâmol-1; for Src SH3,
¢¢H0.5-0.15 ) 3.1 kJâmol-1; T¢¢S0.5-0.15 ) 4.4 kJâmol-1).
These data are consistent with the removal of salt bridges
giving rise to an increase in the degrees of freedom of the
side chains (conformational entropy) which is almost exactly
compensated for by the enthalpic loss of noncovalent
interactions. Since the Asp100-Arg77 interaction prevails
in the crystal structures solved in conditions of high salt,
the thermodynamic data most likely reflect the removal of
the additional salt bridging interactions outlined above. The
difference in the ¢H and T¢S between Hck and Src under
the different salt conditions could be the result of the
additional interaction that Hck can make involving Glu118
and the observation that Hck Glu99 is better positioned to
interact with Nef Lys82 than Src Glu98.
The salt bridges that form in the complex structures appear
to make a negligible contribution to the free energy of
binding, but are probably important in locating and orientat-
ing the proteins prior to association. Indeed, on looking at
the binding surface of the SH3 domains (Figure 5), there is
little to distinguish them from one another for an incoming
Nef molecule. Topologically, the SH3 binding surfaces are
very similar, and the hydrophobic proline-rich binding sites
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offer little in terms of discrimination. However, the distribu-
tion of charged and polar groups in the RT loop region
clearly shows some major points of possible recognition.
Interestingly, looking at the two tightest binding SH3 domain
surfaces, it becomes apparent that both Hck and Lck have
similar charge distribution (both lacking the basic Arg96).
Thermodynamics of Binding of Full-Length Nef to Src
Family SH3 Domains. As described above, structural
information on Nef complexes to date has been derived from
a deleted Nef construct. NMR data on full-length Nef have
suggested that the N-terminal is largely disordered (50). To
investigate the effects on binding of the N-terminal residues,
ITC studies of the interaction of full-length Nef and Src
family SH3 domains were performed. In the interaction with
Hck and Src SH3 domains, the full-length Nef and the
deleted Nef show very little difference in affinity (Table 1).
The KD reported for the Hck SH3-Nef interaction (0.56 íM)
is weaker than that previously reported [0.19 íM; (16)]. This
is likely to be the result of differences in the Nef proteins
used in the ITC studies. In our data, the HIV-1 NefLA1
(laboratory-adapted strain) variant is used which has Thr in
the 71 position (as described in 19). In the large majority
of more recently isolated HIV-1 strains, and in the HIV-1
NefNL4-3 Thr71Arg construct used by Lee et al. (16), the
Thr is replaced by an Arg. Arg71 can make an additional
hydrogen bonding interaction on binding to SH3 domains
(18) which the Thr71 form cannot (19). This may suggest
that the HIV-1 virus has evolved to bind more tightly to SH3
domains.
The ITC binding data (Table 1) show that the interactions
with the SH3 domains from Hck and Src are all highly
enthalpy driven and a large entropic penalty is paid in each
case. These ¢H and T¢S data are very different from those
obtained for the Nef¢1-57 interactions. This is consistent with
the reduction in conformational entropy and the increase in
noncovalent bond formation resulting from folding of the
N-terminal going to the complex state. It is intriguing that,
despite this possible gross conformational rearrangement, the
affinity is similar for both full-length and deleted protein.
Summary of the Structural and Thermodynamic Basis of
Specificity in Nef-SH3 Domain Binding. The interaction
of SH3 domains with proline-rich sequences in ligands has
been demonstrated to be an essential platform for binding
(16); however, little specificity is offered by these sequences,
and studies adopting peptides as mimics of these interactions
suggest that affinities are low. Thus, both specificity and
increased affinity are likely to be derived from elsewhere in
the binding interface. Previous studies had implicated the
key role of the interactions involving the RT loop of the
SH3 domain (16, 53). In this study, we have investigated
the interaction of four SH3 domains with the protein HIV-1
Nef. X-ray crystal structures and homology modeling show
that for this binding to occur the RT loop of the SH3 domain
has to be highly flexible to form an intimate interaction with
the Nef binding site and several side chains undergo severe
reorientation from their observed positions in the unbound
SH3 structures. The SH3 domain of Hck is found to bind
an order of magnitude more tightly to Nef than its Src family
counterparts. The main variation in amino acids involved
in binding between these domains occurs in the RT loop
region; however, these changes do not seem to improve
affinity by resulting in a large increase in specific interac-
tions. For example, it is hard to see how the substitution of
Ile96 to Arg between Hck and Fyn, respectively, can result
in a decrease in binding of an order of magnitude, since in
the crystal structure of the Fyn SH3-Nef complex the
guanidinium group of the Arg is able to make hydrogen
bonds with the Nef residues at the base of a deep pocket,
and the incorporation of Ile introduces a water molecule into
the pocket, presumably incurring a significant entropic cost
(19). However, based on mutational studies in Fyn, the
presence of the Ile96 residue in the binding interface is
important for high-affinity binding (16).
In the tightest binding interaction between Hck SH3 and
Nef, the residues in the RT loop of the unbound peptide are
highly flexible compared to those of other SH3 domains. In
the RT loop of Hck, Ile96 and His97 replace Arg and Thr,
respectively, in Fyn and Src. These substitutions preclude
a hydrogen bonded network forming, leading to a greater
pliancy. Thus, these residues can facilitate the interaction
with the Nef binding site; since the RT loop is already
mobile, the breaking of hydrogen bonds is not required to
make the interface with the Nef molecule. This is empha-
sized by the fact that the substitution of both Ile and His
into positions 96 and 97 in Fyn gives rise to a higher affinity
interaction (16).
It should be emphasized that the recently solved structures
of two proteins from the Src family of tyrosine kinases (24,
25) show that in the ‘closed’ form the SH3 domain interacts
with a loop region linking the N-lobe of the kinase to the
SH2 domain. The residues in this loop in the ‘closed’ form
adopt a PPII-like helix. Thus, it is possible that the Nef
protein has to compete for this site with this intramolecular
interaction. Furthermore, although this intramolecular in-
teraction is less than optimal and hence weak, since the
sequence of the interacting loop shows some variability
between the various members of the Src family, some
additional level of specificity could be invoked.
Comparison of the SH3 domains reveals the binding of
Hck represents an intriguing variation on the ‘induced fit’
mechanism of binding since although the RT loop of the
high-affinity SH3 ligand is freely available other SH3
domains require the expenditure of additional enthalpy to
break hydrogen bonds to allow this to occur [analogous to
that hypothesized for vascular endothelial growth factor (54)].
This results in an additional level of specificity in SH3
domain interactions providing a further challenge in the
identification of pharmaceutical inhibitors.
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